Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Receive this page by email each issue: [Sign up for eTOCs]

December 2003   Volume 61, Supplement 6   [Index by Author] 
       DEDICATION
       INTRODUCTION
       KEYNOTE ADDRESS
       ARTICLES
       I. THE BIOLOGY OF A2A RECEPTORS IN THE BASAL GANGLIA
       II. A2A RECEPTOR MODULATION OF MOTOR SYSTEMS FOR SYMPTOMATIC THERAPY IN PD
       III. A2A RECEPTORS IN NEUROPROTECTION OF DOPAMINERGIC NEURONS
       IV. ADENOSINE A2A RECEPTORS IN NONLOCOMOTOR FEATURES OF PARKINSON'S DISEASE
       V. TRANSLATIONAL PROGRESS IN PURSUIT OF THERAPEUTIC A2A ANTAGONISTS
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

DEDICATION:

Jiang-Fan Chen, Thomas Chase, and Michael Schwarzschild
J. Stephen Fink, MD, PhD (1950–2002)
Neurology 2003 61: S1-2. [Full Text] [Figures Only]  

INTRODUCTION:

Michael A. Schwarzschild, Jiang-Fan Chen, and Thomas N. Chase
A2A antagonists for PD: A prime example of translational neuroscience
Neurology 2003 61: S3-4. [Full Text] [Figures Only] [Data Supplement]  

KEYNOTE ADDRESS:

Bertil B. Fredholm and Per Svenningsson
Adenosine–dopamine interactions: Development of a concept and some comments on therapeutic possibilities
Neurology 2003 61: S5-9. [Abstract] [Full Text] [Figures Only]  

ARTICLES:

I. THE BIOLOGY OF A2A RECEPTORS IN THE BASAL GANGLIA:

Per Svenningsson and Bertil B. Fredholm
Introduction: Exciting news about A2A receptors
Neurology 2003 61: S10-11. [Full Text]  

Diane L. Rosin, Barbara D. Hettinger, Amy Lee, and Joel Linden
Anatomy of adenosine A2A receptors in brain: Morphological substrates for integration of striatal function
Neurology 2003 61: S12-18. [Abstract] [Full Text] [Figures Only]  

K. Fuxe, L.F. Agnati, K. Jacobsen, J. Hillion, M. Canals, M. Torvinen, B. Tinner-Staines, W. Staines, D. Rosin, A. Terasmaa, P. Popoli, G. Leo, V. Vergoni, C. Lluis, F. Ciruela, R. Franco, and S. Ferré
Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson’s disease
Neurology 2003 61: S19-23. [Abstract] [Full Text] [Figures Only]  

S.N. Schiffmann, D. Dassesse, P. d’Alcantara, C. Ledent, S. Swillens, and Michele Zoli
A2A receptor and striatal cellular functions: Regulation of gene expression, currents, and synaptic transmission
Neurology 2003 61: S24-29. [Abstract] [Full Text] [Figures Only]  

II. A2A RECEPTOR MODULATION OF MOTOR SYSTEMS FOR SYMPTOMATIC THERAPY IN PD:

David G. Standaert
Introduction: Adenosine A2A receptor modulation of motor systems for symptomatic therapy in Parkinson’s disease
Neurology 2003 61: S30-31. [Full Text]  

Peter Jenner
A2A antagonists as novel non-dopaminergic therapy for motor dysfunction in PD
Neurology 2003 61: S32-38. [Abstract] [Full Text] [Figures Only]  

Anna R. Carta, Annalisa Pinna, Elisabetta Tronci, and Micaela Morelli
Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats
Neurology 2003 61: S39-43. [Abstract] [Full Text] [Figures Only]  

Akihisa Mori and Tomomi Shindou
Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: A potential mechanism for the antiparkinsonian effects of A2A antagonists
Neurology 2003 61: S44-48. [Abstract] [Full Text] [Figures Only]  

III. A2A RECEPTORS IN NEUROPROTECTION OF DOPAMINERGIC NEURONS:

Felicita Pedata, Anna Maria Pugliese, Alessia Melani, and Marco Gianfriddo
Introduction: A2A receptors in neuroprotection of dopaminergic neurons
Neurology 2003 61: S49-50. [Full Text]  

Alberto Ascherio and Honglei Chen
Caffeinated clues from epidemiology of Parkinson’s disease
Neurology 2003 61: S51-54. [Full Text] [Figures Only]  

Michael A. Schwarzschild, Kui Xu, Emin Oztas, Jacobus P. Petzer, Kay Castagnoli, Neal Castagnoli, Jr., and Jiang-Fan Chen
Neuroprotection by caffeine and more specific A2A receptor antagonists in animal models of Parkinson’s disease
Neurology 2003 61: S55-61. [Abstract] [Full Text] [Figures Only]  

Neal Castagnoli, Jr., Jacobus P. Petzer, Salome Steyn, Kay Castagnoli, Jiang-Fan Chen, Michael A. Schwarzschild, and Cornelis J. Van der Schyf
Monoamine oxidase B inhibition and neuroprotection: Studies on selective adenosine A2A receptor antagonists
Neurology 2003 61: S62-68. [Abstract] [Full Text] [Figures Only]  

P. Popoli, C. Frank, M.T. Tebano, R.L. Potenza, A. Pintor, M.R. Domenici, V. Nazzicone, A. Pèzzola, and R. Reggio
Modulation of glutamate release and excitotoxicity by adenosine A2A receptors
Neurology 2003 61: S69-71. [Abstract] [Full Text] [Figures Only]  

IV. ADENOSINE A2A RECEPTORS IN NONLOCOMOTOR FEATURES OF PARKINSON'S DISEASE:

Ennio Ongini
Introduction: Adenosine A2A receptors in nonlocomotor features of Parkinson’s disease: Introduction
Neurology 2003 61: S72-73. [Full Text]  

Jiang-Fan Chen, Silva Fredduzzi, Elena Bastia, Liqun Yu, Rosario Moratalla, Ennio Ongini, and Michael A. Schwarzschild
Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation: Implications for the treatment of dyskinesias in Parkinson’s disease
Neurology 2003 61: S74-81. [Abstract] [Full Text] [Figures Only]  

Malika El Yacoubi, Jean Costentin, and Jean-Marie Vaugeois
Adenosine A2A receptors and depression
Neurology 2003 61: S82-87. [Abstract] [Full Text] [Figures Only]  

Scott M. Weiss, Emma Whawell, Rebecca Upton, and Colin T. Dourish
Potential for antipsychotic and psychotomimetic effects of A2A receptor modulation
Neurology 2003 61: S88-93. [Abstract] [Full Text] [Figures Only]  

Yoshihiro Urade, Naomi Eguchi, Wei-Min Qu, Mie Sakata, Zhi-Li Huang, Jiang-Fan Chen, Michael A. Schwarzschild, J. Stephen Fink, and Osamu Hayaishi
Minireview: Sleep regulation in adenosine A2A receptor-deficient mice
Neurology 2003 61: S94-96. [Full Text] [Figures Only]  

V. TRANSLATIONAL PROGRESS IN PURSUIT OF THERAPEUTIC A2A ANTAGONISTS:

Hiroshi Kase
Industry forum: Progress in pursuit of therapeutic A2A antagonists: The adenosine A2A receptor selective antagonist KW6002: Research and development toward a novel nondopaminergic therapy for Parkinson’s disease
Neurology 2003 61: S97-100. [Abstract] [Full Text] [Figures Only]  

S.M. Weiss, K. Benwell, I.A. Cliffe, R.J. Gillespie, A.R. Knight, J. Lerpiniere, A. Misra, R.M. Pratt, D. Revell, R. Upton, and C.T. Dourish
Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson’s disease
Neurology 2003 61: S101-106. [Abstract] [Full Text] [Figures Only]  

T.N. Chase, F. Bibbiani, W. Bara-Jimenez, T. Dimitrova, and J.D. Oh-Lee
Translating A2A antagonist KW6002 from animal models to parkinsonian patients
Neurology 2003 61: S107-111. [Abstract] [Full Text] [Figures Only]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.